Mckinley Capital Management LLC Neurocrine Biosciences Inc Transaction History

Mckinley Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$86.91 - $108.33 $4.71 Million - $5.87 Million	-54,216 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$96.16 - $135.15 $9.6 Million - $13.5 Million	-99,884 Reduced 64.82%	54,216 $5.21 Million
Q2 2020 Jul 27, 2020	SELL	$85.09 - $130.36 $524,920 - $804,190	-6,169 Reduced 3.85%	154,100 $18.8 Million
Q1 2020 May 05, 2020	SELL	$75.11 - $113.76 $112,064 - $169,729	-1,492 Reduced 0.92%	160,269 $13.9 Million
Q4 2019 Jan 23, 2020	BUY	$86.8 - $118.57 $2.46 Million - $3.37 Million	28,393 Added 21.29%	161,761 $17.4 Million
Q3 2019 Nov 12, 2019	SELL	$83.82 - $101.5 $1.14 Million - $1.38 Million	-13,617 Reduced 9.26%	133,368 $12 Million
Q2 2019 Aug 07, 2019	SELL	$72.24 - $91.27 $2.12 Million - $2.68 Million	-29,403 Reduced 16.67%	146,985 $12.4 Million
Q1 2019 May 02, 2019	BUY	$69.31 - $91.53 $257,140 - $339,576	3,710 Added 2.15%	176,388 $15.5 Million
Q4 2018 Feb 11, 2019	SELL	$68.32 - $124.36 $190,066 - $345,969	-2,782 Reduced 1.59%	172,678 $12.3 Million
Q3 2018 Nov 08, 2018	BUY	$98.88 - $125.85 $4.8 Million - $6.11 Million	48,562 Added 38.27%	175,460 $21.6 Million
Q2 2018 Jul 13, 2018	BUY	$75.3 - $105.99 $138,024 - $194,279	1,833 Added 1.47%	126,898 $12.5 Million
Q1 2018 May 04, 2018	SELL	$75.88 - $92.43 $1.04 Million - $1.27 Million	-13,759 Reduced 9.91%	125,065 $10.4 Million
Q4 2017 Feb 08, 2018	BUY	$58.53 - $77.59 $8.13 Million - $10.8 Million	138,824	138,824 $10.8 Million

626

94M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.